465 filings
15-12G
SIOX
Sio Gene Therapies Inc.
25 Apr 23
Securities registration termination
4:04pm
EFFECT
SIOX
Sio Gene Therapies Inc.
25 Apr 23
Notice of effectiveness
12:15am
POS AM
SIOX
Sio Gene Therapies Inc.
17 Apr 23
Prospectus update (post-effective amendment)
4:15pm
S-8 POS
SIOX
Sio Gene Therapies Inc.
17 Apr 23
Registration of securities for employees (post-effective amendment)
4:12pm
25-NSE
SIOX
Sio Gene Therapies Inc.
12 Apr 23
Exchange delisting
8:52am
25
5816o 0a1d044ni
6 Apr 23
Voluntary exchange delisting
4:07pm
8-K
zcimkzx6r3pgplsy
6 Apr 23
Departure of Directors or Certain Officers
4:06pm
DEFA14A
xpew1
16 Mar 23
Additional proxy soliciting materials
9:36pm
8-K
shy63s1et2h9r6ns
15 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:25pm
DEFM14A
ozyv6vb630au n5f
21 Feb 23
Proxy related to merger
4:05pm
DEFA14A
64pn2n ciolw79m
14 Feb 23
Additional proxy soliciting materials
7:03am
8-K
nut1psk 0rj81
14 Feb 23
Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
7:01am
SC 13G/A
tpgt1t
13 Feb 23
Sio Gene Therapies / SUVRETTA CAPITAL MANAGEMENT ownership change
8:53am
SC 13G
44ze4ohx4xlbi
10 Feb 23
Sio Gene Therapies / Rubric Capital Management ownership change
4:00pm
PREM14A
1c15oildcmga6eqh1
8 Feb 23
Preliminary proxy related to merger
5:56pm
DEFA14A
v1pbf8lsdpn9nge
14 Dec 22
Additional proxy soliciting materials
4:10pm
8-K
ejvrpdkzrp1f7ibvm
14 Dec 22
Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution
4:04pm
8-K
terj0t1di9het6bnf
10 Nov 22
Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results
7:03am